This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zapantis, A. Articles by Couldry, R. Search for Related Content PubMed PubMed Citation Articles by Zapantis, A. Articles by Couldry, R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2005, p. 2629-2634, Vol. 43, No. 6
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.6.2629-2634.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Nationwide Antibiogram Analysis Using NCCLS M39-A Guidelines

Nova Southeastern University, College of Pharmacy, Fort Lauderdale, Florida,¹ University of Kansas, School of Pharmacy, Kansas City, Kansas,² University of Kansas, School of Medicine, Kansas City, Kansas³

Received 13 October 2004/ Returned for modification 3 December 2004/ Accepted 24 February 2005

Lack of standardization in antibiogram (ABGM) preparation (the overall profile of antimicrobial susceptibility results of a microbial species to a battery of antimicrobial agents) has not been addressed until recently. The objective of this study was to analyze current antibiograms using the recently published NCCLS M39-A guidelines for preparation of antibiograms to identify areas for improvement in the reporting of antibiogram susceptibility data. Antibiograms from across the United States were obtained by various methods, including direct mailings, Internet searches, and professional contacts. Each ABGM collected was analyzed using prospectively defined elements from the M39-A guidelines. Additionally, seven quality indicators were also evaluated to look for the reporting of any atypical or inappropriate susceptibility data. The 209 antibiograms collected from 149 institutions showed at least 85% compliance to 5 of the 10 M39-A elements analyzed. Clinically relevant elements not met included annual analysis, duplicate isolate notation, and the exclusion of organisms with fewer than 10 isolates. As for the quality indicators evaluated, unexpected results included the 7% of antibiograms that reported <100% vancomycin susceptibility for Staphylococcus aureus, 24% that had inconsistent beta-lactam susceptibility for Staphylococcus aureus, 20% that reported <100% imipenem susceptibility for Escherichia coli, and 37% that reported >0% ampicillin susceptibility for Klebsiella pneumoniae. These findings suggest that antibiograms should be reviewed thoroughly by infectious disease specialists (physicians and pharmacists), clinical microbiologists, and infection control personnel for identification of abnormal findings prior to distribution.

This article has been cited by other articles:

• Bantar, C., Alcazar, G., Franco, D., Salamone, F., Vesco, E., Stieben, T., Obaid, F., Fiorillo, A., Izaguirre, M., Oliva, M. E. (2007). Are laboratory-based antibiograms reliable to guide the selection of empirical antimicrobial treatment in patients with hospital-acquired infections?. J Antimicrob Chemother 59: 140-143 [Abstract] [Full Text]